University of Patras
Η συμμετοχή του συστήματος των λιποπρωτεϊνών στη μεταβολική ενεργοποίηση του λιπώδους ιστού
Abstract
dc:descriptionMorbid obesity and accompanied metabolic disorders show an increasing prevalenceworldwide, at an alarming rate. Despite the intense research effort, there is no effective pharmacological intervention to this date. Metabolic activation of white adipose tissue into brown (Brown into White – BRITE) is considered a promising strategy for the treatment of morbid obesity, which has subsequently attracted great research interest over the years. Apolipoprotein E (APOE) has recently been proven to be an important contributor to dietinduced obesity. Based on our published data and current knowledge in the field, APOE expression in the brain is a potent mediator of the processes leading to diet-induced obesity, while hepatic APOE expression contributes to resistance to obesity. The aim of this doctoral study is to evaluate the effect of hepatic overexpression of modified APOE forms in thedevelopment of obesity and in metabolic regulation of white adipose tissue mitochondria. The study focuses on APOE4259 and APOE4mut1, two genetically engineered forms of APOE4, sincetheir overexpression in the periphery has been shown to be superior to wild-type APOE anddoes not cause hypertriglyceridemia. According to the results of the present study, APOE4259and APOE4mut1 demonstrated an inhibitory effect in in vitro experiments of the differentiation of 3T3-L1 preadipocytes into mature adipocytes, through the suppression of PPARγ activity and the de novo synthesis of fatty acids and triglycerides. Furthermore, APOE4mut1 causes an increase in WAT adipocyte metabolic activation of wild-type mice, while its expression in the periphery is not accompanied with the side effect of hypertriglyceridemia. These resultssupport an improved function over wild-type APOE4. However, further investigation of the role of APOE4mut1 in HDL biogenesis and function is warranted, as well as its potential involvement in glucose homeostasis. Consequently, the results of this work advocate the beneficial role of the modified forms of APOE4, highlighting them as possible biological drugs for the treatment of morbid obesity and the accompanied metabolic disorders.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giannopoulou, Panagiota
- Γιαννοπούλου, Παναγιώτα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53246